Original Research

Real-world use of PCSK-9 inhibitors by early adopters: cardiovascular risk factors, statin co-treatment, and short-term adherence in routine clinical practice

Fairman KA, Davis LE, Sclar DA

Therapeutics and Clinical Risk Management 2017, 13:957-965

Published Date: 3 August 2017